Brussels, 28 June 2024

EuropaBio welcomes the recognition by EU leaders of the important role of biotechnology in a prosperous and competitive Europe as part of its Strategic Agenda 2024-2029. The integration of biotech and its applications across industries are already transforming traditional industrial ecosystems and can contribute to strengthening our security and defence, protect our citizens, and making a success of the green transition.

EuropaBio calls for concrete legislative and budgetary commitments, including an EU Biotech Act, from the EU to promote an innovation- and business-friendly environment driven by high political leadership and dedicated structure across institutions to deliver on the Agenda.

 “The Strategic Agenda adopted by EU Leaders is recognition of the biotech revolution, with the EU well positioned to become a global leader of biotech innovation. The 2025 Work Programme of the Commission is an opportunity for commitments to biotech and biomanufacturing, however this comes with a health warning that implementation of existing legislation requires urgent attention and pending legislative proposals must be fit for biotech’’ said EuropaBio Director General Dr. Claire Skentelbery.

EuropaBio looks forward to engaging with policymakers over the coming years to deliver an ambitious agenda for biotech innovation.

------------------------

Media contact

Email:

communications@europabio.org

 About EuropaBio

EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life; to prevent, diagnose, treat, and cure diseases; to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. EuropaBio represents corporate and associate members, plus national biotechnology associations and bioregions. Read more about our work at www.europabio.org.